← Назад

Multiple myeloma

ORPHA:29073DiseaseNot applicableAdult

Ассоциированные гены (1)

CCND1
cyclin D1
Major susceptibility factor in
OMIM: 168461

Фенотипы (31)

Очень частый (80–99%)2
HP:0000938Osteopenia
HP:0002756Pathologic fracture
Частый (30–79%)13
HP:0000100Nephrotic syndrome
HP:0000112Nephropathy
HP:0000980Pallor
HP:0001903Anemia
HP:0001919Acute kidney injury
HP:0002152Hyperproteinemia
HP:0002653Bone pain
HP:0002797Osteolysis
HP:0003237Increased circulating IgG level
HP:0003259Elevated circulating creatinine concentration
HP:0003324Generalized muscle weakness
HP:0004313Decreased circulating antibody level
HP:0012378Fatigue
Периодический (5–29%)13
HP:0000014Abnormality of the bladder
HP:0000098Tall stature
HP:0001824Weight loss
HP:0002176Spinal cord compression
HP:0002808Kyphosis
HP:0002953Vertebral compression fracture
HP:0003072Hypercalcemia
HP:0003261Increased circulating IgA level
HP:0003401Paresthesia
HP:0004341Abnormality of vitamin B12 metabolism
HP:0009830Peripheral neuropathy
HP:0012185Constrictive median neuropathy
HP:0012719Functional abnormality of the gastrointestinal tract
Очень редкий (1–4%)3
HP:0001744Splenomegaly
HP:0002202Pleural effusion
HP:0002716Lymphadenopathy

Эпидемиология (9)

Prevalence at birth
1-9 / 100 000
United States
Annual incidence
1-9 / 100 000
Worldwide
Point prevalence
1-5 / 10 000
Europe
Annual incidence
1-9 / 100 000
France
Annual incidence
1-9 / 100 000
Europe
Annual incidence
1-9 / 100 000
United States
Annual incidence
1-9 / 100 000
Iran, Islamic Republic of
Annual incidence
1-9 / 100 000
Australia
Annual incidence
1-9 / 100 000
Denmark

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы